Antimicrobial Agents Practice Questions

Q: Anaerobic bacteria are intrinsically resistant to which of the following antibiotics?

Aminoglycosides (e.g., gentamicin). ***Aminoglycosides (e.g., gentamicin)*** - Anaerobic bacteria lack the **oxygen-dependent transport systems** necessary to take up aminoglycosides into the bacterial cell. - This results in **intrinsic resistance** because the drug cannot reach its intracellular ribosomal target. *Beta-lactams (e.g., penicillin)* - While some anaerobes (like certain *Bacteroides* species) can be resistant to specific beta-lactams due to **beta-lactamase production**, it's not an intrinsic resistance across all anaerobes to all beta-lactams. - Many anaerobes are **susceptible to penicillin**, especially those that do not produce beta-lactamase, or to beta-lactamase inhibitors combination drugs. *Chloramphenicol (broad-spectrum antibiotic)* - Chloramphenicol is effective against many anaerobic bacteria by inhibiting **protein synthesis**. - Anaerobes are generally **susceptible** to chloramphenicol, and it is not an antibiotic to which they are intrinsically resistant. *Metronidazole (used for anaerobic infections)* - Metronidazole is a **prodrug** that requires anaerobic conditions to become activated. - It is highly effective against most obligate anaerobes and is a common choice for treating **anaerobic infections**, indicating susceptibility, not intrinsic resistance.

Q: Prolonged use of which drug has been implicated in the causation of subacute myelo-optic neuropathy (SMON)?

Quiniodochlor. ***Quiniodochlor*** - **Quiniodochlor** (also known as clioquinol) is an antimicrobial agent whose prolonged use was historically linked to **subacute myelo-optic neuropathy (SMON)**, particularly in Japan. - SMON is characterized by ascending sensory disturbances, motor weakness, and visual impairment due to damage to the spinal cord and optic nerves. *Diloxanide furoate* - **Diloxanide furoate** is an effective luminal amebicide used for asymptomatic carriers of **Entamoeba histolytica**. - Its primary side effects are mild gastrointestinal disturbances, and it is not associated with neurotoxicity like SMON. *Furazolidone* - **Furazolidone** is a nitrofuran antimicrobial used to treat bacterial and protozoal infections, particularly in the gastrointestinal tract. - While it can cause gastrointestinal upset, peripheral neuropathy, and hemolysis in G6PD-deficient individuals, it is not implicated in SMON. *Emetine* - **Emetine** is an alkaloid used as an anti-amebic agent, typically for severe amebiasis. - Its main toxicities include **cardiac toxicity** (e.g., arrhythmias, heart failure), neuromuscular weakness, and gastrointestinal issues, but not SMON.

Q: Which of the following aminoglycoside antibiotics has the highest risk of causing ototoxicity?

Neomycin. ***Neomycin*** - **Neomycin** has the highest risk of **ototoxicity** among the aminoglycosides due to its significant accumulation in inner ear fluid. - It is typically reserved for **topical** or **oral administration** for local effects (e.g., bowel decontamination) to minimize systemic absorption and ototoxic risk [2]. *Kanamycin* - **Kanamycin** is an aminoglycoside with significant ototoxic potential, especially with prolonged use or high doses [1]. - While ototoxic, its risk is generally considered to be lower than Neomycin, which is rarely used systemically due to toxicity [1]. *Amikacin* - **Amikacin** is an aminoglycoside known for its broad spectrum of activity against resistant gram-negative bacteria, and it also carries a risk of ototoxicity [4]. - It is often used in severe infections, and its risk of ototoxicity is monitored, but it's not as high as neomycin [4]. *Gentamicin* - **Gentamicin** is a commonly used aminoglycoside for treating serious bacterial infections, and ototoxicity is a known adverse effect [3]. - While ototoxic, its relative risk is considered lower than neomycin and comparable to other commonly used aminoglycosides when therapeutic drug monitoring is employed [3].

Q: Why is a regimen of four drugs recommended for a TB patient on the first visit?

To prevent emergence of drug-resistant strains. ***To prevent emergence of drug-resistant strains*** - Using a **four-drug regimen** at the initial stage significantly reduces the likelihood of **Mycobacterium tuberculosis** developing resistance to any single drug. - This strategy ensures that even if a small number of bacteria are naturally resistant to one drug, the other drugs will still be effective in killing them, preventing the proliferation of **resistant strains**. *To minimize treatment duration* - While a multi-drug regimen is effective, its primary goal is not to minimize treatment duration but rather to ensure **eradication of the infection** and prevent resistance. - Treatment duration is determined by the need to kill both actively multiplying and dormant bacteria, which typically takes several months even with multiple drugs. *To reduce bacterial load effectively* - Reducing bacterial load is certainly a goal of TB treatment, but the use of four drugs is specifically aimed at achieving this while simultaneously preventing **drug resistance**. - A single effective drug could reduce bacterial load, but it would quickly lead to the emergence of resistant bacteria, making the long-term goal of **cure** impossible. *None of the options* - This option is incorrect because the primary reason for a **four-drug regimen** in TB treatment is indeed to prevent the emergence of **drug-resistant strains**.

Q: A patient with pulmonary tuberculosis, who is receiving anti-tuberculosis therapy consisting of rifampicin, isoniazid, ethambutol, and pyrazinamide, should be advised to take which of the following supplements?

Pyridoxine. ***Pyridoxine*** - **Isoniazid** in the anti-tuberculosis regimen can cause **peripheral neuropathy** by interfering with **pyridoxine (vitamin B6)** metabolism. - Supplementation with **pyridoxine** is advised to prevent this neurotoxic side effect, especially in patients at higher risk such as those with diabetes, malnutrition, or alcoholism. *Niacin* - **Niacin (vitamin B3)** deficiency can lead to **pellagra**, characterized by dermatitis, diarrhea, and dementia. - While important for general health, niacin supplementation is not specifically required to counteract side effects of standard anti-tuberculosis drugs. *Riboflavin* - **Riboflavin (vitamin B2)** is essential for various metabolic processes and cellular energy production. - There is no direct significant depletion or interference with riboflavin metabolism caused by the common anti-tuberculosis drugs. *Thiamine* - **Thiamine (vitamin B1)** deficiency can lead to **beriberi** and neurological symptoms, particularly in those with chronic alcoholism. - While thiamine is crucial for neurological function, antitubercular drugs do not specifically deplete or interfere with its metabolism to the extent of requiring routine supplementation.

Q: Rifampicin acts by inhibiting which of the following?

DNA Dependent RNA polymerase. ***DNA Dependent RNA polymerase*** - **Rifampicin** works by binding to the **beta-subunit** of bacterial **DNA-dependent RNA polymerase**, preventing the initiation of RNA synthesis [2]. - This action is **bactericidal** and is crucial for its effectiveness against **Mycobacterium tuberculosis** and other bacteria [2]. *RNA dependent DNA polymerase* - This enzyme is also known as **reverse transcriptase** and is found in **retroviruses**, not bacteria [1]. - While it is a target for antiretroviral drugs, it is **not the target of rifampicin** [1]. *Mycolic acid inhibition* - **Mycolic acid** synthesis is a target for antitubercular drugs like **isoniazid**, which inhibits **mycolic acid production**. - Rifampicin does **not directly inhibit mycolic acid synthesis** but rather interferes with RNA transcription. *Mycolic acid incorporation defects* - This mechanism is characteristic of drugs like **ethambutol**, which interferes with the **polymerization of arabinogalactan**, thus hindering the proper incorporation of mycolic acid into the cell wall. - Rifampicin's mechanism of action is **distinct** from interfering with mycolic acid incorporation.

Q: A patient diagnosed as having ventilator-associated pneumonia is on treatment with ceftriaxone and amikacin. Culture and sensitivity turned out to be positive for ESBL-producing Klebsiella infection. The most appropriate next action should be:

Change over to imipenem. ***Change over to imipenem*** - **ESBL-producing bacteria** are resistant to most beta-lactam antibiotics, including ceftriaxone. **Carbapenems** like imipenem are the drugs of choice for severe infections caused by ESBL producers. - Switching to imipenem provides **effective empirical coverage** given the updated culture and sensitivity results, ensuring appropriate treatment for the multidrug-resistant organism. *Continue same antibiotic but at higher dose* - ESBL-producing bacteria are **resistant to ceftriaxone**, making it ineffective even at higher doses. - Increasing the dose of an ineffective antibiotic delays appropriate treatment and contributes to **antibiotic resistance**. *Replace ceftriaxone with ceftazidime* - Ceftazidime is also a **third-generation cephalosporin** and is generally ineffective against ESBL-producing organisms. - Switching to another cephalosporin would represent a continuation of **inappropriate antibiotic therapy**. *Remove amikacin and add quinolone* - While quinolones may have activity against some Gram-negative bacteria, their effectiveness against **ESBL-producing Klebsiella** is variable and often compromised by resistance. - **Amikacin** (an aminoglycoside) is a broad-spectrum antibiotic often used in combination for severe infections, and its removal without clear resistance or adverse effects may reduce coverage, especially for synergistic effects against multidrug-resistant organisms.

Q: All of the following beta-lactam antibiotics possess antipseudomonal action, except:

Ceftriaxone. ***Ceftriaxone*** - **Ceftriaxone** is a third-generation cephalosporin that has broad-spectrum activity but **lacks reliable antipseudomonal activity**. - While effective against many **Gram-positive** and **Gram-negative bacteria**, it is not a recommended choice for treating **Pseudomonas aeruginosa infections**. *Piperacillin* - **Piperacillin** is an extended-spectrum penicillin (often combined with **tazobactam**) known for its potent activity against **Pseudomonas aeruginosa**. - It is frequently used in empirical treatment of severe infections where **pseudomonal coverage** is critical. *Ceftazidime* - **Ceftazidime** is a third-generation cephalosporin specifically developed to have strong activity against **Pseudomonas aeruginosa**. - It is a key antibiotic in the treatment of **pseudomonal infections**, particularly those affecting the **lungs** or **urinary tract**. *Cefoperazone* - **Cefoperazone** is a third-generation cephalosporin that demonstrates good antipseudomonal activity, especially when combined with a **beta-lactamase inhibitor** like **sulbactam**. - It is used in the treatment of various infections caused by **P. aeruginosa** and other **Gram-negative bacteria**.

Q: Hypothyroidism is caused by which of the following anti-tubercular drugs?

Ethionamide. ***Ethionamide*** - Ethionamide is a known **thiocarbamide derivative** that can inhibit thyroid hormone synthesis, leading to **hypothyroidism**. - It interferes with the binding of iodine to tyrosine residues within thyroglobulin, reducing the production of **T3 and T4 hormones**. *Streptomycin* - Streptomycin is an **aminoglycoside antibiotic** primarily associated with **ototoxicity** (vestibular and cochlear damage) and **nephrotoxicity**. - It does not have a well-documented association with thyroid dysfunction or hypothyroidism. *Thioacetazone* - Thioacetazone is a **second-line anti-tubercular drug** most commonly associated with severe skin reactions like **Stevens-Johnson syndrome (SJS)** and **toxic epidermal necrolysis (TEN)**. - While it can cause various side effects, hypothyroidism is not a typical or significant adverse effect. *Ethambutol* - Ethambutol's primary and most commonly recognized adverse effect is **ocular toxicity**, specifically **optic neuritis**, which can lead to red-green color blindness and decreased visual acuity. - It does not interfere with thyroid function or promote hypothyroidism.

Question 1

Anaerobic bacteria are intrinsically resistant to which of the following antibiotics?

Accepted Answer

Aminoglycosides (e.g., gentamicin)

Answer

Beta-lactams (e.g., penicillin)

Answer

Chloramphenicol (broad-spectrum antibiotic)

Answer

Metronidazole (used for anaerobic infections)

Question 2

Prolonged use of which drug has been implicated in the causation of subacute myelo-optic neuropathy (SMON)?

Accepted Answer

Quiniodochlor

Answer

Diloxanide furoate

Answer

Furazolidone

Answer

Emetine

Question 3

Which of the following aminoglycoside antibiotics has the highest risk of causing ototoxicity?

Accepted Answer

Neomycin

Answer

Amikacin

Answer

Kanamycin

Answer

Gentamicin

Question 4

Why is a regimen of four drugs recommended for a TB patient on the first visit?

Accepted Answer

To prevent emergence of drug-resistant strains

Answer

To reduce bacterial load effectively

Answer

To minimize treatment duration

Answer

None of the options

Question 5

A patient with pulmonary tuberculosis, who is receiving anti-tuberculosis therapy consisting of rifampicin, isoniazid, ethambutol, and pyrazinamide, should be advised to take which of the following supplements?

Accepted Answer

Pyridoxine

Answer

Niacin

Answer

Riboflavin

Answer

Thiamine

Question 6

Rifampicin acts by inhibiting which of the following?

Accepted Answer

DNA Dependent RNA polymerase

Answer

RNA dependent DNA polymerase

Answer

Mycolic acid inhibition

Answer

Mycolic acid incorporation defects

Question 7

A patient diagnosed as having ventilator-associated pneumonia is on treatment with ceftriaxone and amikacin. Culture and sensitivity turned out to be positive for ESBL-producing Klebsiella infection. The most appropriate next action should be:

Accepted Answer

Change over to imipenem

Answer

Continue same antibiotic but at higher dose

Answer

Remove amikacin and add quinolone

Answer

Replace ceftriaxone with ceftazidime

Question 8

All of the following beta-lactam antibiotics possess antipseudomonal action, except:

Accepted Answer

Ceftriaxone

Answer

Ceftazidime

Answer

Cefoperazone

Answer

Piperacillin

Question 9

A 30-year-old female patient complains of a cough with sputum, and is a known case of tuberculosis who is currently taking rifampin for the same. All of the following are true about this drug except:

Accepted Answer

It binds with the alpha-subunit of prokaryotic RNA polymerase

Answer

It inhibits transcription

Answer

It binds with the beta-subunit of prokaryotic RNA polymerase

Answer

It is metabolized by CYP450 enzymes

Question 10

Hypothyroidism is caused by which of the following anti-tubercular drugs?

Accepted Answer

Ethionamide

Answer

Ethambutol

Answer

Thioacetazone

Answer

Streptomycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?